Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
544.52
+2.83 (0.52%)
At close: Aug 31, 2026, 4:00 PM EDT
545.80
+1.28 (0.24%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Vertex Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
3,3342,9873,1903,0762,9652,7702,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,0731,984
Revenue Growth
12.45%7.82%9.55%10.98%12.06%2.96%15.66%11.61%6.11%13.30%9.34%6.39%13.52%13.22%11.10%17.65%22.46%21.64%27.32%28.98%
Gross Profit
1,8511,6331,7501,6841,5791,4281,4901,5031,3071,5591,3251,3551,3991,3651,3251,4001,3471,2511,2571,281
Operating Income
1,2691,1391,2631,2391,1541,0311,1121,132934.91,2169561,0911,1361,1241,0581,1531,1321,0351,0021,082
Net Income
1,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1851.9
Earnings Per Share
4.314.024.654.203.992.493.504.01-13.924.213.713.973.522.693.143.593.132.962.993.28
EPS Growth
8.02%61.45%32.88%4.74%--40.86%-5.64%1.01%-56.51%18.08%10.59%12.46%-9.12%5.02%9.45%1109.96%18.88%30.38%29.64%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Trikafta / Kaftrio
2,4972,3552,5732,6542,5512,5362,7212,5852,4492,4842,3332,2742,2402,0972,0222,0111,8931,7621,6931,556
Alyftrek
573.6424.4380.1247156.853.9--------------
Casgevy
76.442.954.316.930.414.282------------
Journavx
49.62926.719.6121.3--------------
Revenue (Total)
3,3342,9873,1903,0762,9652,7702,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,0731,984

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
13,64212,99712,32012,01012,02911,35811,22411,22810,18914,55313,71613,62812,59411,49610,8919,7719,2538,2387,5256,961
Total Debt
1,9781,9872,0361,8351,5271,6491,7501,774933.4721.3808.4744.7767.6789.2899.7824.6847.3872.5967.4876.8
Net Cash (Debt)
11,66411,01010,28410,17510,5019,7099,4749,4549,25513,83112,90812,88411,82610,7069,9918,9468,4067,3666,5586,084
Net Cash Growth
11.07%13.41%8.55%7.63%13.46%-29.81%-26.60%-26.62%-21.74%29.19%29.19%44.01%40.68%45.36%52.36%47.04%44.58%22.25%14.71%8.56%
Net Cash Per Share
45.7042.9640.1639.5040.5637.4136.3736.2235.8652.9749.4749.4445.4141.1338.3834.4732.4928.5625.5223.43

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
1,1251,4284981,2411,073818.9584.61,370-3,7541,307234.61,2681,134899.91,078955.51,140956.2995927.2
Capital Expenditures
-112.2-133.4-149.4-101.8-145.7-40.7-92.6-67.7-69-68.4-58.1-40.6-59.6-42.1-33.6-54.2-53.3-63.6-61.8-52.4
Free Cash Flow
1,0131,295348.61,140927.4778.24921,302-3,8231,238176.51,2281,075857.81,045901.31,087892.6933.2874.8
Free Cash Flow Growth
9.25%66.37%-29.15%-12.48%--37.15%178.75%6.05%-44.35%-83.11%36.23%-1.08%-3.90%11.96%3.03%-5.00%110.26%19.35%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
55.52%54.66%54.87%54.74%53.25%51.53%51.16%54.24%49.41%57.94%52.63%54.55%56.11%57.49%57.55%59.97%61.35%59.62%60.67%64.54%
Operating Margin
38.05%38.13%39.60%40.27%38.93%37.22%38.20%40.82%35.34%45.20%37.97%43.93%45.58%47.34%45.94%49.40%51.54%49.36%48.35%54.55%
Pretax Margin
41.75%41.95%41.72%42.22%43.28%26.37%39.03%44.16%-128.18%47.54%45.58%47.48%46.59%37.54%46.76%50.40%46.64%45.52%42.02%54.57%
Profit Margin
32.99%34.53%37.34%35.20%34.84%23.33%31.35%37.71%-135.83%40.87%38.48%41.69%36.73%29.47%35.56%39.86%36.91%36.33%37.16%42.94%
FCF Margin
30.39%43.35%10.93%37.04%31.28%28.09%16.90%46.98%-144.49%46.02%7.01%49.44%43.11%36.12%45.37%38.61%49.47%42.55%45.03%44.09%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
28.6226.1529.1027.3231.43----26.8628.9725.8726.9424.8522.3122.6922.5627.1123.8421.62
Forward PE
25.3623.3122.6120.3223.6026.8822.6626.3928.0724.8524.4421.9222.7021.8918.8319.6719.4518.1216.4214.48
P/FCF Ratio
33.2130.5736.0230.0932.67----29.0531.4221.3423.3720.8218.8919.4719.0327.1123.1824.52
PS Ratio
10.029.289.588.5710.0111.229.4111.3011.7010.6010.629.309.548.808.308.548.638.367.376.60